Replies to post #521377 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Hey Jon Doe UK!

Tried and didn't work with Argos. Let us know how this trial turns out in another 10+ years when it gets done with p3.

Have a good one buddy. Any more rat trial updates for us today?!

[biosectinvestor]

No it isn’t. Your definition of personalized is not correct. Plus melanoma has very few antigens. There is no need for “personalization”. It’s buzzwords over substance.

It has some level of “customization” but they have preselected the antigens and it is very likely the “customization” is not customized at all. The analysis is likely useful for Melanoma for very little differentiation. It sounds good and fits them into a buzzword construct and they don’t really need to do the work. It is artificial and it is really no skin off their back to offer all 20 antigens, or not. They can premade the most common combinations they think are best and “test” to see which one to give. But that is more along the lines of “mass customization” than personalization. They jumped for the wrong buzzword because they want to be seen a certain way.

[norisknorewards]

not good for Novocure, thats for d sure